DICE Therapeutics, Inc. Profile Avatar - Palmy Investing

DICE Therapeutics, Inc.

DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulat…
Biotechnology
US, South San Francisco [HQ]

Filings / Resources

Link Index · Filing Reader · 10K/10Q
Loading may take some time.
SEC
2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30
Transcripts

Gather insights into the latest earnings call through our transcripts.

Other Docs/Resources
Transcripts Investor Relations EDGAR DICE's Industry Healthcare Analysis Biotechnology Analysis US Analysis South San Francisco Analysis
End of DICE's Analysis
CIK: 1645569 CUSIP: 23345J104 ISIN: US23345J1043 LEI: - UEI: -
Secondary Listings
DICE has no secondary listings inside our databases.